Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 3

Effect of nondipper hypertension on coronary artery disease progression in patients with chronic coronary syndrome

Pages
1273–1280
Publication Date
2022-11-03
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In our study, we showed that nondipper hypertension is a new parameter that is effective in CAD progression.Key words: Coronary artery disease, nondipper hypertension, progression

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: It has been suggested that there is a significant progress in coronary artery disease (CAD) by many pathophysiological mechanisms.
📊
Key Findings & Data:Nondipper hypertension (NDH) has been shown to have higher target organ damage and have a higher rate of cardiovascular mortality and morbidity.
💡
Conclusion & Impact:In our study, we showed that nondipper hypertension is a new parameter that is effective in CAD progression.Key words: Coronary artery disease, nondipper hypertension, progression
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: It has been suggested that there is a significant progress in coronary artery disease (CAD) by many pathophysiological mechanisms. Nondipper hypertension (NDH) has been shown to have higher target organ damage and have a higher rate of cardiovascular mortality and morbidity. In this study, we investigated the effect of nondipper hypertension on the progression of coronary atherosclerosis. Materials and methods: A total of 186 patients who underwent coronary angiography twice between 6 months and 3 years were included in the study. Coronary angiography was repeated on the admission day due to angina or positive exercise test and the patients were divided into groups. Results: Progression of coronary artery disease was detected in 58 of 186 patients. Seventy-one of the total patients were found to be nondipper hypertensive. Nondipper hypertension, hypertension, diabetes mellitus, low-density lipoprotein, and total cholesterol were found to be effective in the progression of CAD. Among these parameters, it was seen that nondipper hypertension and hyperlipidemia were the most important independent risk factors. Conclusion: Coronary artery disease is a progressive disease, and this progression depends on many reasons. In our study, we showed that nondipper hypertension is a new parameter that is effective in CAD progression.Key words: Coronary artery disease, nondipper hypertension, progression

🔖

Cite This Article

KALAY, N., ELÇİK, D., KELEŞOĞLU, Ş., ÇETİNKAYA, Z., BOYLU, S., YURT, R., DOĞAN, A., İNANÇ, M. T., DURAN, M. (2022). Effect of nondipper hypertension on coronary artery disease progression in patients with chronic coronary syndrome. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 3, 1273–1280. https://ajindex.com/articles/609594

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Goldberg IJ, Sharma G, Fisher EA. atherosclerosis: making a u turn. Annual Review of Medicine 2020
  2. 27 (71): 191-201. doi: 10.1146/annurev-med-042418-011108 2. Costopoulos C, Maehara A, Huang Y, Brown AJ, Gillard JH et al. Heterogeneity of plaque structural stress is increased in plaques leading to mace: insights from the PROSPECT study. Journal of the American College of Cardiology Cardiovasc Imaging 2020
  3. 13 (5): 1206-1218. doi: 10.1016/j.jcmg.2019.05.024 3. Millar-Craig MW, Bishop CN, Raftery EB. Circadian variation of blood-pressure. Lancet. 1978
  4. 1 (8068): 795-797. doi: 10.1016/s0140-6736(78)92998-7 4. Fujii T, Uzu T, Nishimura M, Takeji M, Kuroda S et al. Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension. American Journal of Kidney Diseases 1999
  5. 33 (1): 29-35. doi: 10.1016/s0272-6386(99)70254-4 5. Pierdomenico SD, Bucci A, Costantini F, Lapenna D, Cuccurullo F et al. Circadian blood pressure changes and myocardial ischemia in hypertensive patients with coronary artery disease. Journal of The American College of Cardiology 1998
  6. doi: 10.1016/s0735-1097(98)00163-6 6. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. Journal of Hypertension 2002
  7. 20 (11): 2183-2189. doi: 10.1097/00004872-200211000-00017 7. Berry C, L’Allier PL, Grégoire J, Lespérance J, Levesque S et al. Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression. Circulation 2007
  8. 115(14): 1851-7. doi: 10.1161/CIRCULATIONAHA.106.655654 8. van Buuren F, Dahm JB, Horskotte D. Stent restenosis and thrombosis: etiology, treatment, and outcomes. Minerva Medicine 2012
  9. 103(6): 503-11 9. Reiber JHC. Morphologic and densitometric quantitation of coronary stenoses
  10. an overview of existing quantitation techniques. In: Reiber JHC, Serruys PW (editors) New Developments in Quantitative Coronary Arteriography. Developments in Cardiovascular Medicine, vol 87. Springer, Dordrecht. 1988. doi: 10.1007/978-94-009-1309-7_4 10. Lespérance J, Hudon G, White C, Laurier J, Waters D. Comparison by quantitative angiographic assessment of coronary stenoses of one view showing the severest narrowing to two orthogonal views. American Journal of Cardiology 1989
  11. doi: 10.1016/0002-9149(89)90421-9 11. Kaski JC, Chester